Dov Elefant
2021 - Cellectar Biosciences
In 2021, Dov Elefant earned a total compensation of $838.2K as Former Vice President and Chief Financial Officer at Cellectar Biosciences, a 78% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $85,655 |
|---|---|
| Option Awards | $395,600 |
| Salary | $356,895 |
| Total | $838,150 |
Elefant received $395.6K in option awards, accounting for 47% of the total pay in 2021.
Elefant also received $85.7K in non-equity incentive plan and $356.9K in salary.
Rankings
In 2021, Dov Elefant's compensation ranked 9,338th out of 12,406 executives tracked by ExecPay. In other words, Elefant earned more than 24.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,338 out of 12,406 | 25th |
Division Manufacturing | 4,137 out of 5,494 | 25th |
Major group Chemicals And Allied Products | 1,824 out of 2,369 | 23rd |
Industry group Drugs | 1,618 out of 2,090 | 23rd |
Industry Pharmaceutical Preparations | 1,200 out of 1,537 | 22nd |
Source: SEC filing on April 29, 2022.
Elefant's colleagues
We found three more compensation records of executives who worked with Dov Elefant at Cellectar Biosciences in 2021.